Autolus Therapeutics Ltd reported $35.79M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.61B 4.46B Dec/2025
Autolus Therapeutics Ltd USD 35.79M 1.68M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Silence Therapeutics USD 3.73M 2.06M Dec/2025